Correction to: Fragment-based identification of influenza endonuclease inhibitors (Journal of Medicinal Chemistry (2016) 59 (6444-6454) DOI: 10.1021/acs.jmedchem.6b00628);Fragment-Based Identification of Influenza Endonuclease Inhibitors

Journal of Medicinal Chemistry

Volumn 59, Issue 13, 2016, Pages 6444-6454

  Credille, Cy V ^a   Chen, Yao ^a   Cohen, Seth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (1H TETRAZOL 5 YL)PHENYL] 2 [[(4 CHLOROPHENYL)(METHYL)AMINO]METHYL] 5 HYDROXYPYRIDIN 4(1H) ONE; AMIDE; AMINE; AROMATIC AMIDE; BENZYLAMINE DERIVATIVE; CARBOXYLIC ACID; ENDONUCLEASE; ENZYME INHIBITOR; HETEROCYCLIC COMPOUND; HYDROGEN; INFLUENZA ENDONUCLEASE INHIBITOR; KOJIC ACID; PYRIDONE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; PA PROTEIN, INFLUENZA VIRUSES; RNA DIRECTED RNA POLYMERASE; VIRAL PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CELL VIABILITY; CHEMICAL MODIFICATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DEGRADATION; DERIVATIZATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; EC50; ENZYMATIC ASSAY; ENZYME ACTIVITY; HIGH THROUGHPUT SCREENING; HYDROGEN BOND; HYDROLYSIS; IC50; INFLUENZA A VIRUS (H1N1); MDCK CELL LINE; MOLECULAR WEIGHT; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOG; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; RNA REPLICASE; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

EID: 84978648980     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.7b01683     Document Type: Erratum

References (37)

1. Dunning, J.; Baillie, J. K.; Cao, B.; Hayden, F. G. International Severe Acute, R.; Emerging Infection, C., Antiviral combinations for severe influenza Lancet Infect. Dis. 2014, 14 (12) 1259-1270 10.1016/S1473-3099(14)70821-7
2. Mills, C. E.; Robins, J. M.; Lipsitch, M. Transmissibility of 1918 pandemic influenza Nature 2004, 432 (7019) 904-906 10.1038/nature03063
3. Adjusted vaccine effectiveness estimates for influenza seasons from 2005 to 2015. http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm (accessed February 26, 2016).
4. Monod, A.; Swale, C.; Tarus, B.; Tissot, A.; Delmas, B.; Ruigrok, R. W.; Crepin, T.; Slama-Schwok, A. Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza Expert Opin. Drug Discovery 2015, 10 (4) 345-371 10.1517/17460441.2015.1019859
5. Stiver, G. The treatment of influenza with antiviral drugs Can. Med. Assoc. J. 2003, 168 (1) 49-57
6. Administration, U. S. F. a. D. Tamiflu pediatric adverse events: questions and answers. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107840.htm (accessed February 26, 2016).
7. Furuse, Y.; Suzuki, A.; Oshitani, H. Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance Antimicrob. Agents Chemother. 2009, 53 (10) 4457-4463 10.1128/AAC.00650-09
8. Fiore, A. E.; Fry, A.; Shay, D.; Gubareva, L.; Bresee, J. S.; Uyeki, T. M. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity Mortality Wkly. Rep. 2011, 60 (1) 1-24
9. Huang, T. S.; Palese, P.; Krystal, M. Determination of influenza virus proteins required for genome replication J. Virol. 1990, 64 (11) 5669-5673
10. Drake, J. W. Rates of spontaneous mutation among RNA viruses Proc. Natl. Acad. Sci. U. S. A. 1993, 90 (9) 4171-4175 10.1073/pnas.90.9.4171
11. Fodor, E. The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication Acta. Virol. 2013, 57 (2) 113-122 10.4149/av-2013-02-113
12. Plotch, S. J.; Bouloy, M.; Ulmanen, I.; Krug, R. M. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription Cell 1981, 23 (3) 847-858 10.1016/0092-8674(81)90449-9
13. Dias, A.; Bouvier, D.; Crepin, T.; McCarthy, A. A.; Hart, D. J.; Baudin, F.; Cusack, S.; Ruigrok, R. W. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit Nature 2009, 458 (7240) 914-918 10.1038/nature07745
14. Beaton, A. R.; Krug, R. M. Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo Nucleic Acids Res. 1981, 9 (17) 4423-4436 10.1093/nar/9.17.4423
15. Xie, L.; Wartchow, C.; Shia, S.; Uehara, K.; Steffek, M.; Warne, R.; Sutton, J.; Muiru, G. T.; Leonard, V. H.; Bussiere, D. E.; Ma, X. Molecular basis of mRNA cap recognition by Influenza B polymerase PB2 subunit J. Biol. Chem. 2016, 291, 363-370 10.1074/jbc.M115.693051
16. Hatakeyama, D.; Shoji, M.; Yamayoshi, S.; Hirota, T.; Nagae, M.; Yanagisawa, S.; Nakano, M.; Ohmi, N.; Noda, T.; Kawaoka, Y.; Kuzuhara, T. A novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication J. Biol. Chem. 2014, 289 (36) 24980-24994 10.1074/jbc.M114.559708
17. Blok, V.; Cianci, C.; Tibbles, K. W.; Inglis, S. C.; Krystal, M.; Digard, P. Inhibition of the influenza virus RNA-dependent RNA polymerase by antisera directed against the carboxy-terminal region of the PB2 subunit J. Gen. Virol. 1996, 77 (Part 5) 1025-1033 10.1099/0022-1317-77-5-1025
18. DuBois, R. M.; Slavish, P. J.; Baughman, B. M.; Yun, M. K.; Bao, J.; Webby, R. J.; Webb, T. R.; White, S. W. Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease PLoS Pathog. 2012, 8 (8) e1002830 10.1371/journal.ppat.1002830
19. Nakazawa, M.; Kadowaki, S. E.; Watanabe, I.; Kadowaki, Y.; Takei, M.; Fukuda, H. PA subunit of RNA polymerase as a promising target for anti-influenza virus agents Antiviral Res. 2008, 78 (3) 194-201 10.1016/j.antiviral.2007.12.010
20. Tomassini, J.; Selnick, H.; Davies, M. E.; Armstrong, M. E.; Baldwin, J.; Bourgeois, M.; Hastings, J.; Hazuda, D.; Lewis, J.; McClements, W. et al. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds Antimicrob. Agents Chemother. 1994, 38 (12) 2827-2837 10.1128/AAC.38.12.2827
21. Hastings, J. C.; Selnick, H.; Wolanski, B.; Tomassini, J. E. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors Antimicrob. Agents Chemother. 1996, 40 (5) 1304-1307
22. Cianci, C.; Chung, T. D. Y.; Meanwell, N.; Putz, H.; Hagen, M.; Colonno, R. J.; Krystal, M. Identification of N-hydroxamic acid and N-hydroxyimide compounds that inhibit the influenza virus polymerase Antiviral Chem. Chemother. 1996, 7 (6) 353-360 10.1177/095632029600700609
23. Tomassini, J. E.; Davies, M. E.; Hastings, J. C.; Lingham, R.; Mojena, M.; Raghoobar, S. L.; Singh, S. B.; Tkacz, J. S.; Goetz, M. A. A novel antiviral agent which inhibits the endonuclease of influenza viruses Antimicrob. Agents Chemother. 1996, 40 (5) 1189-1193
24. Kuzuhara, T.; Iwai, Y.; Takahashi, H.; Hatakeyama, D.; Echigo, N. Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase PLoS Curr. 2009, 1, RRN1052 10.1371/currents.RRN1052
25. Kowalinski, E.; Zubieta, C.; Wolkerstorfer, A.; Szolar, O. H.; Ruigrok, R. W.; Cusack, S. Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase PLoS Pathog. 2012, 8 (8) e1002831 10.1371/journal.ppat.1002831
26. Sagong, H. Y.; Bauman, J. D.; Patel, D.; Das, K.; Arnold, E.; LaVoie, E. J. Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease J. Med. Chem. 2014, 57 (19) 8086-8098 10.1021/jm500958x
27. Parhi, A. K.; Xiang, A.; Bauman, J. D.; Patel, D.; Vijayan, R. S.; Das, K.; Arnold, E.; Lavoie, E. J. Phenyl substituted 3-hydroxypyridin-2(1H)-ones: inhibitors of influenza A endonuclease Bioorg. Med. Chem. 2013, 21 (21) 6435-6446 10.1016/j.bmc.2013.08.053
28. Bauman, J. D.; Patel, D.; Baker, S. F.; Vijayan, R. S.; Xiang, A.; Parhi, A. K.; Martinez-Sobrido, L.; LaVoie, E. J.; Das, K.; Arnold, E. Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors ACS Chem. Biol. 2013, 8 (11) 2501-2508 10.1021/cb400400j
29. Baughman, B. M.; Jake Slavish, P.; DuBois, R. M.; Boyd, V. A.; White, S. W.; Webb, T. R. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay ACS Chem. Biol. 2012, 7 (3) 526-534 10.1021/cb200439z
30. Jacobsen, J. A.; Fullagar, J. L.; Miller, M. T.; Cohen, S. M. Identifying chelators for metalloprotein inhibitors using a fragment-based approach J. Med. Chem. 2011, 54 (2) 591-602 10.1021/jm101266s
31. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection Drug Discovery Today 2004, 9 (10) 430-431 10.1016/S1359-6446(04)03069-7
32. Sanna, D.; Buglyo, P.; Biro, L.; Micera, G.; Garribba, E. Coordinating properties of pyrone and pyridinone derivatives, tropolone and catechol toward the VO2+ ion: an experimental and computational approach Eur. J. Inorg. Chem. 2012, 2012 (7) 1079-1092 10.1002/ejic.201101249
33. Raha, K.; Merz, K. M., Jr. A quantum mechanics-based scoring function: study of zinc ion-mediated ligand binding J. Am. Chem. Soc. 2004, 126 (4) 1020-1021 10.1021/ja038496i
34. Zhang, J.; Yang, W.; Piquemal, J. P.; Ren, P. Modeling structural coordination and ligand binding in zinc proteins with a polarizable potential J. Chem. Theory Comput. 2012, 8 (4) 1314-1324 10.1021/ct200812y
35. Stevaert, A.; Dallocchio, R.; Dessi, A.; Pala, N.; Rogolino, D.; Sechi, M.; Naesens, L. Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease J. Virol. 2013, 87 (19) 10524-10538 10.1128/JVI.00832-13
36. Sagong, H. Y.; Parhi, A.; Bauman, J. D.; Patel, D.; Vijayan, R. S.; Das, K.; Arnold, E.; LaVoie, E. J. 3-Hydroxyquinolin-2(1H)-ones as inhibitors of influenza A endonuclease ACS Med. Chem. Lett. 2013, 4 (6) 547-550 10.1021/ml4001112
37. Bohm, H. J.; Flohr, A.; Stahl, M. Scaffold hopping Drug Discovery Today: Technol. 2004, 1 (3) 217-224 10.1016/j.ddtec.2004.10.009